Clinical Trial Update: VEGF Trap and Docetaxel in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating VEGF Trap with docetaxel in persistent or recurrent ovarian epithelial cancer, primary peritoneal cancer, or fallopian tube cancer; s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Malignant Tumor of Peritoneum
• Ovarian Epithelial Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• VEGF Trap (aflibercept)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Fallopian Tube Cancer, Malignant Tumor of Peritoneum | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-03-11